Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Core Viewpoint - The market anticipates Cencora (COR) will report a year-over-year increase in earnings driven by higher revenues in its upcoming earnings report for the quarter ended June 2025 [1][3]. Earnings Expectations - Cencora is expected to post quarterly earnings of $3.78 per share, reflecting a year-over-year increase of +13.2% [3]. - Revenues are projected to reach $80.33 billion, representing an 8.2% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 0.39% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for Cencora is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.49% [12]. Earnings Surprise Prediction - A positive Earnings ESP reading suggests a likely earnings beat, especially when combined with a Zacks Rank of 2 (Buy) [10][12]. - Cencora has a Zacks Rank of 2, indicating a strong likelihood of exceeding the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Cencora exceeded the expected earnings of $4.08 per share by delivering $4.42, resulting in a surprise of +8.33% [13]. - The company has beaten consensus EPS estimates in each of the last four quarters [14]. Industry Comparison - Another player in the Zacks Medical Services industry, Organon (OGN), is expected to report earnings of $0.94 per share, indicating a year-over-year decline of -16.1% [18]. - Organon's revenues are projected to be $1.55 billion, down 3.4% from the previous year [18]. - Despite a stable consensus EPS estimate, Organon has a positive Earnings ESP of +5.32% and a Zacks Rank of 2, suggesting it may also beat consensus estimates [19].